GEN Exclusives

More »

GEN News Highlights

Back to Item »

Human Genome Sciences Earns $75M from Novartis as HCV Drug Gets Prepared for Regulatory Submissions

Upon approval albinterferon alfa-2b will be marketed as Zalbin in the U.S. and Joulferon in the rest of world.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »